These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7760444)

  • 1. In vitro adsorption of phenobarbital, chlorpheniramine maleate, and theophylline by four commercially available activated charcoal suspensions.
    Cooney DO
    J Toxicol Clin Toxicol; 1995; 33(3):213-7. PubMed ID: 7760444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capacity and effectiveness of diosmectite and charcoal in trapping the compounds causing the most frequent intoxications in acute medicine: A comparative study.
    Mináriková M; Fojtikova V; Vyskočilová E; Sedláček J; Šikut M; Borek-Dohalska L; Stiborová M; Martinkova M
    Environ Toxicol Pharmacol; 2017 Jun; 52():214-220. PubMed ID: 28445845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of thermodynamic parameters for the activated charcoal-phenobarbitone adsorption system.
    Agarwal S; Pal TK
    Boll Chim Farm; 1999 Sep; 138(8):422-6. PubMed ID: 10622108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
    Hoffman A; Levy G
    Pharm Res; 1990 Mar; 7(3):242-6. PubMed ID: 2339096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.
    Modi NB; Veng-Pedersen P; Wurster DE; Berg MJ; Schottelius DD
    Pharm Res; 1994 Feb; 11(2):318-23. PubMed ID: 8165195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies.
    Hoegberg LC; Angelo HR; Christophersen AB; Christensen HR
    J Toxicol Clin Toxicol; 2002; 40(1):59-67. PubMed ID: 11990205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of multiple-component adsorption on the surface of activated carbon using a model system of benzyl alcohol and phenobarbital.
    Alkhamis KA; Wurster DE
    Pharm Dev Technol; 2003; 8(2):127-33. PubMed ID: 12760563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model selection for the adsorption of phenobarbital by activated charcoal.
    Burke GM; Wurster DE; Buraphacheep V; Berg MJ; Veng-Pedersen P; Schottelius DD
    Pharm Res; 1991 Feb; 8(2):228-31. PubMed ID: 2023872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of particle size on the adsorption of theophylline onto activated charcoal, in vitro study.
    Nakamura T; Kawasaki N; Matsumoto K; Tanada S
    Chudoku Kenkyu; 2003 Jan; 16(1):57-62. PubMed ID: 12712543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of mitomycin C adsorption by activated charcoal.
    Shah IA; Lindup WE; McCulloch PG
    J Pharm Pharmacol; 1998 Mar; 50(3):251-6. PubMed ID: 9600715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ethanol and pH on the adsorption of drugs from simulated gastric fluid onto activated charcoal.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2003 Jun; 25(3):310-3. PubMed ID: 12766559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccharin sodium as a potential sweetener for antidotal charcoal.
    Cooney DO
    Am J Hosp Pharm; 1977 Dec; 34(12):1342-4. PubMed ID: 596384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Container residue after the administration of aqueous activated charcoal products.
    Krenzelok EP; Lush RM
    Am J Emerg Med; 1991 Mar; 9(2):144-6. PubMed ID: 1994942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of the activated charcoal suspension composition based on a mixture design approach.
    Ronowicz J; Kupcewicz B; Pałkowski Ł; Krysiński J
    Acta Pharm; 2015 Mar; 65(1):83-90. PubMed ID: 25781707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.
    Berg MJ; Rose JQ; Wurster DE; Rahman S; Fincham RW; Schottelius DD
    Ther Drug Monit; 1987; 9(1):41-7. PubMed ID: 3554627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of adsorption from multicomponent solutions by activated carbon using single-solute parameters.
    Wurster DE; Alkhamis KA; Matheson LE
    AAPS PharmSciTech; 2000 Aug; 1(3):E25. PubMed ID: 14727911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined paracetamol and amitriptyline adsorption to activated charcoal.
    Hoegberg LC; Groenlykke TB; Abildtrup U; Angelo HR
    Clin Toxicol (Phila); 2010 Nov; 48(9):898-903. PubMed ID: 20932101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution.
    Hoffman RS; Chiang WK; Howland MA; Weisman RS; Goldfrank LR
    J Toxicol Clin Toxicol; 1991; 29(2):191-201. PubMed ID: 2051506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.
    Rademaker CM; van Dijk A; de Vries MH; Kadir F; Glerum JH
    Pharm Weekbl Sci; 1989 Apr; 11(2):56-60. PubMed ID: 2726418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.